ClassID:

95301

C07D417/12 - page 4 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#901
20220194932
2022-06-23

Inhibitors of the notch transcriptional activation complex and methods for use of the same

#902
20220193055
2022-06-23

METHODS OF TREATING NEUROLOGICAL, METABOLIC, AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED PIOGLITAZONE

#903
20220185806
2022-06-16

INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 30

#904
20220185779
2022-06-16

Compounds, compositions and methods

#905
20220184035
2022-06-16

HBV inhibitor and its use

#906
20220183295
2022-06-16

MICROBIOCIDAL 2-ACYLAMINO-THIAZOLE-4-CARBOXAMIDE DERIVATIVES

#907
20220177625
2022-06-09

Curable composition, cured product, and compound

#908
20220177495
2022-06-09

Pyridinamine-pyridone and pyrimidinamine-pyridone compounds

#909
20220177470
2022-06-09

Sulfoximine glycosidase inhibitors

#910
20220177465
2022-06-09

Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes

#911
20220177464
2022-06-09

HCK INHIBITORS FOR THE TREATMENT OF FIBROSIS AND CANCER

#912
20220177459
2022-06-09

AROMATIC AMINE COMPOUND AND USE THEREOF IN PREPARATION OF AR AND BRD4 DUAL INHIBITORS AND REGULATORS

#913
20220177434
2022-06-09

Modulators of mas-related G-protein receptor X2 and related products and methods

#914
20220169642
2022-06-02

COMPOUNDS FOR THE TREATMENT OF ONCOVIRUS INDUCED CANCER AND METHODS OF USE THEREOF

#915
20220169641
2022-06-02

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

#916
20220169639
2022-06-02

N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

#917
20220169631
2022-06-02

TAIRE FAMILY KINASE INHIBITORS AND USES THEREOF

#918
20220169628
2022-06-02

THERAPEUTIC AGENTS AND METHODS OF TREATMENT

#919
20220169611
2022-06-02

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#920
20220162201
2022-05-26

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

#921
20220162197
2022-05-26

MYST family histone acetyltransferase inhibitors

#922
20220162184
2022-05-26

Quinolyl-containing compound and pharmaceutical composition, and use thereof

#923
20220162167
2022-05-26

SUBSTITUTED BICYCLIC AND TETRACYCLIC QUINONES AND USE THEREOF AS ANTI-CANCER AGENTS

#924
20220153731
2022-05-19

Compounds for Pain Treatment, Compositions Comprising Same, and Methods of Using Same

#925
20220153722
2022-05-19

CDK2/5 DEGRADERS AND USES THEREOF

#926
20220153721
2022-05-19

MAGL inhibitors

#927
20220153711
2022-05-19

P14-Kinase Inhibitors and Methods of Using the Same

#928
20220153710
2022-05-19

Compounds

#929
20220153688
2022-05-19

Hydrazone amide derivatives and use thereof in preparation of anti-osteoporosis drugs

#930
20220152009
2022-05-19

Sulfate salt of the free base of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof

#931
20220152008
2022-05-19

Enantiomers of substituted thiazoles as antiviral compounds

#932
20220144816
2022-05-12

RET kinase inhibitors

#933
20220142165
2022-05-12

HETEROCYCLIC COMPOUND AND AGRICULTURAL OR HORTICULTURAL FUNGICIDE

#934
20220135601
2022-05-05

HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE

#935
20220135555
2022-05-05

Crystalline forms of a deoxycytidine kinase inhibitor and uses thereof

#936
20220135554
2022-05-05

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

#937
20220133713
2022-05-05

SIGMA-2 RECEPTOR BINDERS AND THEIR METHOD OF USE

#938
20220127279
2022-04-28

MDM2-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE

#939
20220127227
2022-04-28

Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides

#940
20220119709
2022-04-21

Heteroaryl-thio-substituted pyrones

#941
20220119413
2022-04-21

Heterocycle amines and uses thereof

#942
20220119400
2022-04-21

QUINAZOLINE AND INDOLE COMPOUNDS TO TREAT MEDICAL DISORDERS

#943
20220119375
2022-04-21

3-ARYLOXY-3-ARYL-PROPYLAMINE COMPOUND AND USES THEREOF

#944
20220117955
2022-04-21

4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS

#945
20220112203
2022-04-14

Small molecules active against gram-negative bacteria

#946
20220112185
2022-04-14

NOVEL PHENYL PROPIONIC ACID DERIVATIVES AND USES THEREOF

#947
20220112169
2022-04-14

Indane derivatives for use in the treatment of bacterial infection

#948
20220112159
2022-04-14

Sulfonylureas and related compounds and use of same

#949
20220112157
2022-04-14

MYC-MAX INHIBITOR COMPOUND THERAPEUTICS FOR CANCER TREATMENT, METHODS AND USES ASSOCIATED THEREWITH

#950
20220106303
2022-04-07

HipK4 inhibitors and uses thereof

#951
20220106301
2022-04-07

ACETAMIDO-PHENYLBENZAMIDE DERIVATIVES AND METHODS OF USING THE SAME

#952
20220106279
2022-04-07

CLASS OF MU-OPIOID RECEPTOR AGONISTS

#953
20220106276
2022-04-07

2-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS

#954
20220106275
2022-04-07

RADIOLABELED COMPOUNDS AND USES THEREOF

#955
20220106265
2022-04-07

Compositions and methods for the treatment of cancer

#956
20220105105
2022-04-07

NT5C2 INHIBITORS FOR THE TREATMENT OF CHEMOTHERAPY-RESISTANT ACUTE LYMPHOBLASTIC LEUKEMIA

#957
20220098181
2022-03-31

Compositions and methods for inhibition of the JAK pathway

#958
20220098153
2022-03-31

R-type pyridyloxycarboxylic acid, salt and ester derivative thereof, and preparation method therefor, and herbicidal composition and application thereof

#959
20220089575
2022-03-24

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

#960
20220081430
2022-03-17

Substituted amide compounds useful as farnesoid X receptor modulators

#961
20220081412
2022-03-17

QUINOLINYL-PYRAZINE-CARBOXAMIDE COMPOUNDS AND USES THEREOF

#962
20220073536
2022-03-10

METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISEASES WITH 2,4-PYRIMIDINEDIAMINE COMPOUNDS

#963
20220073507
2022-03-10

Substituted propanamides as inhibitors of nucleases

#964
20220073466
2022-03-10

Pyridyloxy-carboxylate derivative and preparation method therefor, herbicidal composition, and use

#965
20220073460
2022-03-10

Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof

#966
20220073452
2022-03-10

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

#967
20220071966
2022-03-10

INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY

#968
20220064142
2022-03-03

Acyl hydrazone derivative compounds for treating disease

#969
20220064112
2022-03-03

EBNA1 inhibitors and methods using same

#970
20220056022
2022-02-24

RAD51 INHIBITORS

#971
20220056021
2022-02-24

Anticancer compounds

#972
20220056017
2022-02-24

Bicycloheptane pyrrolidine orexin receptor agonists

#973
20220055998
2022-02-24

INHIBITORS OF CYCLIN-DEPENDENT KINASES

#974
20220053763
2022-02-24

PYRIDYLOXY CARBOXYLATE DERIVATIVE, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF

#975
20220048901
2022-02-17

Compositions and methods for modulating inflammatory and degenerative disorder

#976
20220048881
2022-02-17

TRICYCLIC SPIRO COMPOUND

#977
20220048858
2022-02-17

Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides

#978
20220041547
2022-02-10

Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection

#979
20220033393
2022-02-03

Compounds for treating cannabinoid toxicity and acute cannabinoid overdose

#980
20220033392
2022-02-03

Aminothiazole compounds as c-Kit inhibitors

#981
20220031852
2022-02-03

TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS

#982
20220024912
2022-01-27

Compounds for treatment of cancer

#983
20220024910
2022-01-27

Process for making biologically active compounds and intermediates thereof

#984
20220024900
2022-01-27

Compounds and Their Use for Reducing Uric Acid Levels

#985
20220023311
2022-01-27

HEPATITIS B CORE PROTEIN MODULATORS

#986
20220017559
2022-01-20

CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS

#987
20220017508
2022-01-20

Method for preparing a key intermediate for the synthesis of statins

#988
20220017507
2022-01-20

PI-kinase inhibitors with anti-infective activity

#989
20220017506
2022-01-20

Morpholinyl, piperazinyl, oxazepanyl and diazepanyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors

#990
20220017505
2022-01-20

AMINOQUINAZOLINONE AND AMINOISOQUINOLINONE DERIVATIVES AND APPLICATION THEREOF

#991
20220017474
2022-01-20

Polycyclic compound

#992
20220016102
2022-01-20

ER PROTEIN REGULATORS AND USE THEREOF

#993
20220009918
2022-01-13

Chemical Compounds

#994
20220002284
2022-01-06

PESTICIDAL COMPOUNDS

#995
20220002283
2022-01-06

MELOXICAM CO-CRYSTALS

#996
20220002282
2022-01-06

Substituted aminothiazoles as inhibitors of nucleases

#997
20220002281
2022-01-06

Pyrrolidinone derivatives as formyl peptide 2 receptor agonists

#998
20220000851
2022-01-06

Deuterium-enriched pioglitazone

#999
20220000844
2022-01-06

4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels

#1000
20210403862
2021-12-30

METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS

#1001
20210403464
2021-12-30

Crystalline forms of deuterium-enriched pioglitazone

#1002
20210403459
2021-12-30

SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF

#1003
20210403457
2021-12-30

2-oxoimidazolidine-4-carboxamides as NA1.8 inhibitors

#1004
20210403444
2021-12-30

HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF RSV

#1005
20210403435
2021-12-30

HERBICIDAL COMPOUNDS

#1006
20210395244
2021-12-23

Mitogen-activated protein kinase kinase (MEK) degradation compounds and methods of use

#1007
20210395243
2021-12-23

PESTICIDAL COMPOUNDS

#1008
20210395242
2021-12-23

HETEROCYCLIC COMPOUNDS AS AHR MODULATORS

#1009
20210395241
2021-12-23

NLRP MODULATORS

#1010
20210395238
2021-12-23

NADPH OXIDASE 4 INHIBITORS

#1011
20210395196
2021-12-23

HERBICIDAL 2-AZASPIRO[3-5]NONANE COMPOUNDS

#1012
20210387981
2021-12-16

TYK2 kinase inhibitors

#1013
20210387980
2021-12-16

Heterocyclic mitochondrial activity inhibitors and uses thereof

#1014
20210387976
2021-12-16

Herbicidal compounds

#1015
20210380579
2021-12-09

Proteolysis targeting chimera (PROTACS) as degraders of SMARCA2 and /or SMARCA4

#1016
20210380577
2021-12-09

PROCESS FOR MAKING HEPATITIS B CORE PROTEIN MODULATORS

#1017
20210380576
2021-12-09

PESTICIDAL COMPOSITIONS AND METHODS

#1018
20210380575
2021-12-09

Compounds

#1019
20210380562
2021-12-09

Compounds

#1020
20210379076
2021-12-09

ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS

#1021
20210371460
2021-12-02

TARGETED NITROXIDE AGENTS

#1022
20210371430
2021-12-02

Heterocyclic amide for inhibiting RIP1 kinase and uses thereof

#1023
20210371420
2021-12-02

Inhibitors of kinase networks and uses thereof

#1024
20210371409
2021-12-02

GLP-1 receptor modulators

#1025
20210363141
2021-11-25

Dual mechanism inhibitors for the treatment of disease

#1026
20210363140
2021-11-25

Compounds useful for inhibiting RET kinase

#1027
20210363136
2021-11-25

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#1028
20210363115
2021-11-25

CYCLOOLEFIN SUBSTITUTED HETEROAROMATIC COMPOUNDS AND THEIR USE

#1029
20210355127
2021-11-18

Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors

#1030
20210355119
2021-11-18

Cyano quinoline amide compounds as HER2 inhibitors and methods of use

#1031
20210353777
2021-11-18

SPECIFIC CONJUGATION LINKERS, SPECIFIC IMMUNOCONJUGATES THEREOF, METHODS OF MAKING AND USES SUCH CONJUGATES THEREOF

#1032
20210353606
2021-11-18

PqsR inverse agonists

#1033
20210353602
2021-11-18

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

#1034
20210347769
2021-11-11

Method for producing optically active compound

#1035
20210347768
2021-11-11

Bicyclic compounds useful as GPR120 modulators

#1036
20210347752
2021-11-11

BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS

#1037
20210347748
2021-11-11

Indane derivatives for use in the treatment of bacterial infection

#1038
20210346523
2021-11-11

Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof

#1039
20210346364
2021-11-11

Oxazolidinones as TarO inhibitors

#1040
20210346358
2021-11-11

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

#1041
20210340138
2021-11-04

Compounds and methods for inhibiting fascin

#1042
20210340126
2021-11-04

SUBSTITUTED PHENYLPYRROLECARBOXAMIDES WITH THERAPEUTIC ACTIVITY IN HIV

#1043
20210340112
2021-11-04

NOVEL HETEROARYL BUTANOIC ACID DERIVATIVES

#1044
20210332036
2021-10-28

PYRIMIDINE AND PYRAZINE HDAC1,2 INHIBITORS

#1045
20210323957
2021-10-21

Class of DNA gyrase and/or topoisomerase IV inhibitors with activity against gram-positive and gram-negative bacteria

#1046
20210323956
2021-10-21

Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors

#1047
20210323916
2021-10-21

Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

#1048
20210317112
2021-10-14

HETEROCYCLIC COMPOUNDS AS PESTICIDES

#1049
20210309654
2021-10-07

5-substituted 4-amino-1H-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof

#1050
20210309620
2021-10-07

Substituted imidazoles for preventing and/or treating cell or tissue necrosis

#1051
20210309615
2021-10-07

PHENYL AMINO PYRIMIDINE COMPOUNDS AND USES THEREOF

#1052
20210309614
2021-10-07

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#1053
20210300914
2021-09-30

Substituted pyrimidines as LRKK2 inhibitors

#1054
20210300913
2021-09-30

Deuterated derivatives of lanifibranor

#1055
20210300912
2021-09-30

ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF

#1056
20210300907
2021-09-30

Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119

#1057
20210300882
2021-09-30

Modulators of myocyte lipid accumulation and insulin resistance and methods of use thereof

#1058
20210299113
2021-09-30

TRPV4 antagonists

#1059
20210292328
2021-09-23

Benzoimidazole derivatives as anticancer agents

#1060
20210292305
2021-09-23

Cyclic Ureas

#1061
20210292299
2021-09-23

Taire family kinase inhibitors and uses thereof

#1062
20210292298
2021-09-23

Bi-functional compounds and methods for targeted ubiquitination of androgen receptor

#1063
20210292283
2021-09-23

6-MEMBERED HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#1064
20210290613
2021-09-23

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

#1065
20210284658
2021-09-16

Thiazole derivatives and pharmaceutically acceptable salts thereof

#1066
20210284653
2021-09-16

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

#1067
20210284631
2021-09-16

Cyano-substituted heterocycles with activity as inhibitors of USP30

#1068
20210283123
2021-09-16

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

#1069
20210282402
2021-09-16

Pesticidal compositions and methods

#1070
20210277056
2021-09-09

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

#1071
20210277007
2021-09-09

Hetero-halo inhibitors of histone deacetylase

#1072
20210276993
2021-09-09

CRYSTAL FORMS OF THIAZOLE COMPOUND AND APPLICATION THEREOF

#1073
20210275526
2021-09-09

Methods for treating Huntington's disease

#1074
20210269429
2021-09-02

N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof

#1075
20210267993
2021-09-02

Thiadiazine derivatives

#1076
20210267971
2021-09-02

2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES

#1077
20210261587
2021-08-26

STRAD-binding agents and uses thereof

#1078
20210261537
2021-08-26

INHIBITORS OF SARM1

#1079
20210260027
2021-08-26

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

#1080
20210253562
2021-08-19

ACYLSUFONAMIDE COMPOUNDS USEFUL AS EP3 RECEPTOR ANTAGONISTS

#1081
20210253561
2021-08-19

Selective ligands for modulation of GIRK channels

#1082
20210253547
2021-08-19

BETA- AND GAMMA-AMINO-ISOQUINOLINE AMIDE COMPOUNDS AND SUBSTITUTED BENZAMIDE COMPOUNDS

#1083
20210253530
2021-08-19

C-met modulators and methods of use

#1084
20210246115
2021-08-12

ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF

#1085
20210238171
2021-08-05

Benzisoxazole compound

#1086
20210238162
2021-08-05

CHEMICAL COMPOUNDS

#1087
20210238152
2021-08-05

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

#1088
20210236505
2021-08-05

SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS

#1089
20210236471
2021-08-05

Riluzole prodrugs and their use

#1090
20210236470
2021-08-05

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

#1091
20210230183
2021-07-29

Compositions and methods for treating cancer

#1092
20210230153
2021-07-29

Aryl hydrocarbon receptor (AHR) agonists and uses thereof

#1093
20210230141
2021-07-29

Tetrahydroindazoles and medical uses thereof

#1094
20210230129
2021-07-29

Compounds and compositions for treating conditions associated with NLRP activity

#1095
20210230116
2021-07-29

1,4-substituted piperidine derivatives

#1096
20210228549
2021-07-29

Riluzole prodrugs and their use

#1097
20210221778
2021-07-22

Inhibitors of heat shock factors and uses thereof

#1098
20210220408
2021-07-22

ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE

#1099
20210220351
2021-07-22

Pyruvate kinase activators for use in therapy

#1100
20210214323
2021-07-15

NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

#1101
20210206757
2021-07-08

N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors

#1102
20210198250
2021-07-01

Succinate and fumarate acid addition salts of piperazine derivatives

#1103
20210198208
2021-07-01

4-SUBSTITUTED AMINOISOQUINOLINE DERIVATIVES

#1104
20210198206
2021-07-01

Therapeutic compounds and compositions

#1105
20210198203
2021-07-01

COMPOUNDS, COMPOSITIONS AND METHODS

#1106
20210188835
2021-06-24

Methods and compositions useful in treating cancer and reducing WNT mediated effects in a cell

#1107
20210188820
2021-06-24

Antagonists of the muscarinic acetylcholine receptor M4

#1108
20210188804
2021-06-24

Potassium channel inhibitors

#1109
20210188786
2021-06-24

Substituted 1,2,4-triazoles and methods of use

#1110
20210186958
2021-06-24

Glycosidase inhibitors

#1111
20210186022
2021-06-24

Microbiocidal thiazole derivatives

#1112
20210186021
2021-06-24

Diaminotriazine compounds

#1113
20210179627
2021-06-17

3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#1114
20210179603
2021-06-17

CYCLOPROPANAMINE COMPOUND AND USE THEREOF

#1115
20210179602
2021-06-17

5-thiazolecarboxamide kinase inhibitor and uses thereof

#1116
20210179560
2021-06-17

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#1117
20210179556
2021-06-17

PRIMARY CARBOXAMIDES AS BTK INHIBITORS

#1118
20210171537
2021-06-10

Benzenesulfonamide compouds and their use as therapeutic agents

#1119
20210171531
2021-06-10

MASP-2 inhibitors and methods of use

#1120
20210171516
2021-06-10

THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF

#1121
20210171513
2021-06-10

Compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same

#1122
20210171503
2021-06-10

GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF

#1123
20210171477
2021-06-10

Compounds and compositions for treating conditions associated with NLRP activity

#1124
20210171474
2021-06-10

Glycolate oxidase inhibitors for the treatment of disease

#1125
20210171455
2021-06-10

Alpha-5 beta-1 inhibitors

#1126
20210171440
2021-06-10

1,4-disubstituted imidazole derivative

#1127
20210163494
2021-06-03

OX2R compounds

#1128
20210163468
2021-06-03

PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA SELECTIVE AGONISTS FOR INHIBITION OF RETINAL PIGMENT EPITHELIUM DEGENERATION OR GEOGRAPHIC ATROPHY

#1129
20210163467
2021-06-03

Morpholine derivates as inhibitors of Vps34

#1130
20210163466
2021-06-03

EP4 antagonist

#1131
20210163456
2021-06-03

Certain pladienolide compounds and methods of use

#1132
20210163426
2021-06-03

Cycloolefin substituted heteroaromatic compounds and their use

#1133
20210161873
2021-06-03

Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof

#1134
20210155614
2021-05-27

Delta-opioid receptor agonists

#1135
20210155597
2021-05-27

COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN

#1136
20210154204
2021-05-27

Inhibitors of receptor interacting protein kinase I for the treatment of disease

#1137
20210147407
2021-05-20

Phenylacetamides as inhibitors of rock

#1138
20210147406
2021-05-20

5-membered and bicyclic heterocyclic amides as inhibitors of rock

#1139
20210147405
2021-05-20

BICYCLIC HETEROAROMATIC UREA OR CARBAMATE COMPOUNDS FOR USE IN THERAPY

#1140
20210147399
2021-05-20

Cardiac sarcomere inhibitors

#1141
20210147385
2021-05-20

Compounds and methods for targeting pathogenic blood vessels

#1142
20210147355
2021-05-20

Dopamine D2 receptor ligands

#1143
20210139472
2021-05-13

Ferroportin inhibitors

#1144
20210139467
2021-05-13

MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE

#1145
20210139438
2021-05-13

HDAC inhibitors and therapeutic methods using the same

#1146
20210137938
2021-05-13

NUPR1 INHIBITION FOR TREATING CANCER

#1147
20210130338
2021-05-06

Heparanase inhibitors and use thereof

#1148
20210122739
2021-04-29

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

#1149
20210122730
2021-04-29

GLUCOCORTICOID RECEPTOR MODULATORS

#1150
20210120817
2021-04-29

Plant disease control agent

#1151
20210115064
2021-04-22

Compositions and methods for treating cancer

#1152
20210114981
2021-04-22

Elimination of hepatitis b virus with antiviral agents

#1153
20210107914
2021-04-15

OX2R compounds

#1154
20210107869
2021-04-15

Urea derivative or pharmacologically acceptable salt thereof

#1155
20210107868
2021-04-15

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#1156
20210101884
2021-04-08

Compositions and methods for preparing and using azetidines

#1157
20210100246
2021-04-08

PYRIDYL-FORMAMIDINES HAVING A FUNGICIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND USE THEREOF

#1158
20210094924
2021-04-01

Indoleamine 2,3-dioxygenase inhibitor, method for preparation and use thereof

#1159
20210094923
2021-04-01

Pyrimidine compounds useful as tyrosine kinase inhibitors

#1160
20210094913
2021-04-01

INHIBITORS OF EGFR AND METHODS OF USE THEREOF

#1161
20210093608
2021-04-01

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

#1162
20210087184
2021-03-25

AMINO-BENZOISOTHIAZOLE AND AMINO-BENZOISOTHIADIAZOLE AMIDE COMPOUNDS

#1163
20210087163
2021-03-25

PHENOXY THIOPHENE SULFONAMIDES AND OTHER COMPOUNDS FOR USE AS INHIBITORS OF BACTERIAL GLUCURONIDASE

#1164
20210078988
2021-03-18

MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE

#1165
20210078962
2021-03-18

Prodrugs of riluzole and their method of use

#1166
20210078952
2021-03-18

Human plasma kallikrein inhibitors

#1167
20210078947
2021-03-18

Therapeutic compounds and methods of use thereof

#1168
20210070767
2021-03-11

Apelin receptor (APJ) agonists and uses thereof

#1169
20210070747
2021-03-11

2(1H)-QUINOLINONE DERIVATIVE

#1170
20210070739
2021-03-11

2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds

#1171
20210070713
2021-03-11

Pesticidal compounds

#1172
20210070707
2021-03-11

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

#1173
20210069203
2021-03-11

DNA-PK inhibitors

#1174
20210061778
2021-03-04

Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

#1175
20210061775
2021-03-04

ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS

#1176
20210061760
2021-03-04

Substituted benzamides

#1177
20210053960
2021-02-25

Pyrazole MAGL inhibitors

#1178
20210053924
2021-02-25

Heterocyclic compounds as pesticides

#1179
20210052747
2021-02-25

Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof

#1180
20210052584
2021-02-25

Modulators of cystic fibrosis transmembrane conductance regulator

#1181
20210052514
2021-02-25

Immunomodulator compounds

#1182
20210047313
2021-02-18

Antitumor compound for activating gene and degrading HER2, preparation method thereof, and application thereof

#1183
20210047276
2021-02-18

Human plasma kallikrein inhibitors

#1184
20210047275
2021-02-18

Human plasma kallikrein inhibitors

#1185
20210047274
2021-02-18

Herbicidal compounds

#1186
20210046073
2021-02-18

2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors

#1187
20210040486
2021-02-11

INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST ANTI-TUMOUR IMMUNE RESPONSES, AND USES THEREOF

#1188
20210040079
2021-02-11

10H-phenothiazine ferroptosis inhibitor as well as the preparative method and the use thereof

#1189
20210040078
2021-02-11

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

#1190
20210032235
2021-02-04

Crystalline forms of dasatinib

#1191
20210032230
2021-02-04

Alkoxybenzo-five-membered (six-membered) heterocyclic amine compound and pharmaceutical use thereof

#1192
20210030873
2021-02-04

Photosensitizer and derivatives and application thereof

#1193
20210024476
2021-01-28

Simplified structural mimetics of AIPS as quorum sensing inhibitors

#1194
20210017167
2021-01-21

Inhibitors of lysine gingipain

#1195
20210017153
2021-01-21

AHR inhibitors and uses thereof

#1196
20210017136
2021-01-21

Heterocyclic compounds as pesticides

#1197
20210009580
2021-01-14

AZTREONAM DERIVATIVES AND USES THEREOF

#1198
20210009577
2021-01-14

KRAS G12C inhibitors and methods of using the same

#1199
20210009574
2021-01-14

Amine derivative and an organic electroluminescent device thereof

#1200
20210009531
2021-01-14

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS